The Specialty PACS Market Size was valued at USD 3.3 billion in 2023, and expected to reach USD 5.29 billion by 2031, and grow at a CAGR of 6.1% over the forecast period 2024-2031.
The specialty PACS market is on an upward trajectory, fueled by an aging population with rising disease rates. This creates a surge in demand for advanced medical imaging, perfectly addressed by specialty PACS solutions. Governments are actively promoting healthcare IT adoption, further propelling the market. Additionally, rising investments in medical imaging technology and wider use of imaging equipment in healthcare facilities contribute to the market's growth. However, budgetary constraints may pose a challenge in the coming years.
Get more information on Specialty PACS Market - Request Sample Report
Furthermore, PACS eliminate the need for costly film-based systems, improving workflow efficiency and offering significant convenience with multi-modality access (X-ray, CT, MRI) across various locations.
Aging Population is major driver
The global population is rapidly aging. For instance, in 2019, there were 703 million people aged 65 or over, and this number is projected to reach 1.5 billion by 2050. This surge in the elderly population, prone to conditions like osteoporosis and osteoarthritis, will significantly increase demand for advanced medical imaging, a key driver for specialty PACS adoption.
Specialty PACS offer significant advantages over traditional systems, improving image quality, data management, accessibility, and workflow efficiency, leading to better diagnoses and patient care.
Budgetary Constraints
Limited funding for hospitals and imaging centers may lead to delays in purchasing new or replacing outdated PACS systems despite the growing need for advanced imaging management solutions.
Technological Advancements
Continuous advancements in specialty PACS, such as real-time image analysis and integration with AI-powered diagnostics, present exciting opportunities for market growth.
The increasing adoption of cloud-based PACS offers advantages like scalability and affordability, potentially expanding the market reach.
Data Security Concerns
Data security breaches pose a significant risk within healthcare, requiring robust security measures for PACS systems.
Transitioning to PACS may require user training and addressing potential resistance to change within healthcare institutions.
The Russia Ukraine war is delivering a devastating blow to the nation's healthcare system, impacting the use of specialty PACS (Picture Archiving and Communication Systems) across various healthcare facilities. Hospitals in war zones are particularly affected, facing service disruptions due to damage, staff displacement, and resource shortages which hinders their ability to utilize PACS for diagnostics and treatment. The surge in trauma cases further strains these limited resources. Ambulatory surgery centers and clinics are not spared either, with many being forced to close or significantly reduce services. Even those remaining functional may see a shift in patient priorities, with non-critical procedures utilizing PACS taking a backseat to urgent care needs. Diagnostic imaging centers are especially vulnerable, as shelling and missile attacks can damage their facilities and disrupt PACS operations. Staff shortages due to displacement only compound these issues. The impact extends to other end-users like rural healthcare facilities as well. Existing disparities in access to advanced medical technology like PACS are likely to worsen due to the war. The displacement of people and the resulting strain on resources further hinder these facilities' ability to invest in or maintain PACS. In conclusion, the war in Ukraine has a significant negative impact on the use of specialty PACS across the healthcare system, leading to potential delays in diagnoses and treatment, reduced access to advanced medical imaging, and an increased burden on remaining healthcare facilities. The long-term impact hinges on the war's duration and severity, alongside the availability of resources for rebuilding the healthcare infrastructure. International aid and post-war reconstruction efforts will be essential in restoring access to advanced medical technologies like PACS for the Ukrainian people.
An economic slowdown can create a challenging environment for the use of specialty PACS across the healthcare system. While it may lead to delays in procedures and diagnoses reliant on PACS technology, there could be a silver lining. The economic pressure might spur innovation in cost-effective PACS solutions and encourage the adoption of cloud-based options, offering greater accessibility for financially constrained facilities. The long-term impact will depend on the severity of the slowdown, but proactive measures and advancements in cost-effective PACS solutions can help mitigate the challenges and ensure continued access to this vital technology.
Radiology PACS
Cardiology PACS
Pathology PACS
Ophthalmology PACS
Orthopedics PACS
Oncology PACS
Dermatology PACS
Neurology PACS
Endoscopy PACS
Women’s health PACS
Other specialty PACS
The specialty PACS market is segmented by type, with radiology PACS leading the pack in 2023. However, the future belongs to ophthalmology PACS. This segment is expected to experience the fastest growth due to a rise in eye diseases, an increase in ophthalmic surgeries, and continuous advancements in ophthalmic equipment.
Hardware
Software
Services
On-premise specialty PACS
Web/Cloud-based specialty PACS
On-premise PACS have dominated the market and this dominance is due to the greater level of customization they offer compared to web-based solutions. However, the convenience and scalability of cloud-based PACS are expected to challenge this lead in the coming years.
Hospitals
Ambulatory Surgery Centers & Clinics
Diagnostic Imaging Centers
Other End Users
Hospitals currently hold the biggest slice of the specialty PACS market, and this trend is expected to continue. This dominance is fueled by factors like rising patient volumes, growing awareness of early diagnosis, advancements in imaging technology, and the increasing adoption of electronic medical records (EMR) systems.
The specialty PACS market is led by North America, which captured a dominant share with a 4.3% growth rate in 2023. This leadership is fueled by factors like a high burden of chronic diseases, rising hospital adoption of PACS, advanced healthcare facilities with skilled professionals, and significant government investments. However, the Asia-Pacific region is expected to witness the fastest growth. This surge is driven by improvements in healthcare infrastructure, a growing number of well-equipped hospitals, a flourishing R&D sector in healthcare, and continuous advancements in medical technology itself.
Need any customization research on Specialty PACS Market - Enquiry Now
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Some of the major key players are as follows: Canon Inc., Siemens Healthineers, McKesson Corporation, INC Escalon Medical Corp., Intelerad Medical Systems, Eye PACS, LLC, IBM Corporation, Sectra AB, INFINITT Healthcare Co. Ltd., Topcon Corporation, Novarad, Onex Corporation (Carestream Health), Philips Healthcare, Agfa Healthcare, Visbion and Other Players.
In October 2022, Ambra Health, a cloud-based medical image management leader, was acquired by Intelerad, another leader in medical image management. This signifies a trend towards consolidation in the cloud PACS market, aiming to offer a more comprehensive solution for image management.
GE Healthcare, a major player in medical imaging, entered the US PACS market in August 2022 with their Edison True PACS solution. This signifies increased competition and potentially more options for healthcare providers.
Change Healthcare, a healthcare technology leader, announced the successful implementation of their cloud-native Stratus Imaging PACS in November 2022. This demonstrates the growing adoption of cloud-based PACS solutions offering remote access and streamlined workflows for radiology professionals.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 3.3 Billion |
| Market Size by 2031 | US$ 5.29 Billion |
| CAGR | CAGR of 6.1% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments |
|
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Canon Inc., Siemens Healthineers, McKesson Corporation, INC Escalon Medical Corp., Intelerad Medical Systems, Eye PACS, LLC, IBM Corporation, Sectra AB, INFINITT Healthcare Co. Ltd., Topcon Corporation, Novarad, Onex Corporation (Carestream Health), Philips Healthcare, Agfa Healthcare, Visbion |
| DRIVERS |
|
| RESTRAINTS |
|
Ans: The market is expected to reach USD 5.29 billion by 2031.
Ans: The market is grown at a CAGR of 6.1% From 2024 to 2031.
Technological Advancements
The increasing adoption of cloud-based PACS offers advantages like scalability and affordability, potentially expanding the market reach
Ans: The major players are Canon Inc., Siemens Healthineers, McKesson Corporation, INC Escalon Medical Corp., Intelerad Medical Systems, Eye PACS, LLC, IBM Corporation, Sectra AB, INFINITT Healthcare Co. Ltd., Topcon Corporation, Novarad, Onex Corporation (Carestream Health), Philips Healthcare, Agfa Healthcare, Visbion.
Ans: The forecast period of the Specialty PACS Market is 2023-2031.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Specialty PACS Market Segmentation, By Component
9.1 Introduction
9.2 Trend Analysis
9.3 Radiology PACS
9.4 Cardiology PACS
9.5 Pathology PACS
9.6 Ophthalmology PACS
9.7 Orthopedics PACS
9.8 Oncology PACS
9.9 Dermatology PACS
9.10 Neurology PACS
9.11 Endoscopy PACS
9.12 Women’s health PACS
9.13 Other specialty PACS
10. Specialty PACS Market Segmentation, By Component
10.1 Introduction
10.2 Trend Analysis
10.3 Hardware
10.4 Software
10.5 Services
11. Specialty PACS Market Segmentation, By Deployment Model
11.1 Introduction
11.2 Trend Analysis
11.3 On-premise specialty PACS
11.4 Web/Cloud-based specialty PACS
12. Specialty PACS Market Segmentation, By End-User
12.1 Introduction
12.2 Trend Analysis
12.3 Hospitals
12.4 Ambulatory Surgery Centers & Clinics
12.5 Diagnostic Imaging Centers
12.6 Other End Users
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 Trend Analysis
13.2.2 North America Specialty PACS Market by Country
13.2.3 North America Specialty PACS Market By Component
13.2.4 North America Specialty PACS Market By Component
13.2.5 North America Specialty PACS Market By Deployment Model
13.2.6 North America Specialty PACS Market By End-User
13.2.7 USA
13.2.7.1 USA Specialty PACS Market By Component
13.2.7.2 USA Specialty PACS Market By Component
13.2.7.3 USA Specialty PACS Market By Deployment Model
13.2.7.4 USA Specialty PACS Market By End-User
13.2.8 Canada
13.2.8.1 Canada Specialty PACS Market By Component
13.2.8.2 Canada Specialty PACS Market By Component
13.2.8.3 Canada Specialty PACS Market By Deployment Model
13.2.8.4 Canada Specialty PACS Market By End-User
13.2.9 Mexico
13.2.9.1 Mexico Specialty PACS Market By Component
13.2.9.2 Mexico Specialty PACS Market By Component
13.2.9.3 Mexico Specialty PACS Market By Deployment Model
13.2.9.4 Mexico Specialty PACS Market By End-User
13.3 Europe
13.3.1 Trend Analysis
13.3.2 Eastern Europe
13.3.2.1 Eastern Europe Specialty PACS Market by Country
13.3.2.2 Eastern Europe Specialty PACS Market By Component
13.3.2.3 Eastern Europe Specialty PACS Market By Component
13.3.2.4 Eastern Europe Specialty PACS Market By Deployment Model
13.3.2.5 Eastern Europe Specialty PACS Market By End-User
13.3.2.6 Poland
13.3.2.6.1 Poland Specialty PACS Market By Component
13.3.2.6.2 Poland Specialty PACS Market By Component
13.3.2.6.3 Poland Specialty PACS Market By Deployment Model
13.3.2.6.4 Poland Specialty PACS Market By End-User
13.3.2.7 Romania
13.3.2.7.1 Romania Specialty PACS Market By Component
13.3.2.7.2 Romania Specialty PACS Market By Component
13.3.2.7.3 Romania Specialty PACS Market By Deployment Model
13.3.2.7.4 Romania Specialty PACS Market By End-User
13.3.2.8 Hungary
13.3.2.8.1 Hungary Specialty PACS Market By Component
13.3.2.8.2 Hungary Specialty PACS Market By Component
13.3.2.8.3 Hungary Specialty PACS Market By Deployment Model
13.3.2.8.4 Hungary Specialty PACS Market By End-User
13.3.2.9 Turkey
13.3.2.9.1 Turkey Specialty PACS Market By Component
13.3.2.9.2 Turkey Specialty PACS Market By Component
13.3.2.9.3 Turkey Specialty PACS Market By Deployment Model
13.3.2.9.4 Turkey Specialty PACS Market By End-User
13.3.2.10 Rest of Eastern Europe
13.3.2.10.1 Rest of Eastern Europe Specialty PACS Market By Component
13.3.2.10.2 Rest of Eastern Europe Specialty PACS Market By Component
13.3.2.10.3 Rest of Eastern Europe Specialty PACS Market By Deployment Model
13.3.2.10.4 Rest of Eastern Europe Specialty PACS Market By End-User
13.3.3 Western Europe
13.3.3.1 Western Europe Specialty PACS Market by Country
13.3.3.2 Western Europe Specialty PACS Market By Component
13.3.3.3 Western Europe Specialty PACS Market By Component
13.3.3.4 Western Europe Specialty PACS Market By Deployment Model
13.3.3.5 Western Europe Specialty PACS Market By End-User
13.3.3.6 Germany
13.3.3.6.1 Germany Specialty PACS Market By Component
13.3.3.6.2 Germany Specialty PACS Market By Component
13.3.3.6.3 Germany Specialty PACS Market By Deployment Model
13.3.3.6.4 Germany Specialty PACS Market By End-User
13.3.3.7 France
13.3.3.7.1 France Specialty PACS Market By Component
13.3.3.7.2 France Specialty PACS Market By Component
13.3.3.7.3 France Specialty PACS Market By Deployment Model
13.3.3.7.4 France Specialty PACS Market By End-User
13.3.3.8 UK
13.3.3.8.1 UK Specialty PACS Market By Component
13.3.3.8.2 UK Specialty PACS Market By Component
13.3.3.8.3 UK Specialty PACS Market By Deployment Model
13.3.3.8.4 UK Specialty PACS Market By End-User
13.3.3.9 Italy
13.3.3.9.1 Italy Specialty PACS Market By Component
13.3.3.9.2 Italy Specialty PACS Market By Component
13.3.3.9.3 Italy Specialty PACS Market By Deployment Model
13.3.3.9.4 Italy Specialty PACS Market By End-User
13.3.3.10 Spain
13.3.3.10.1 Spain Specialty PACS Market By Component
13.3.3.10.2 Spain Specialty PACS Market By Component
13.3.3.10.3 Spain Specialty PACS Market By Deployment Model
13.3.3.10.4 Spain Specialty PACS Market By End-User
13.3.3.11 Netherlands
13.3.3.11.1 Netherlands Specialty PACS Market By Component
13.3.3.11.2 Netherlands Specialty PACS Market By Component
13.3.3.11.3 Netherlands Specialty PACS Market By Deployment Model
13.3.3.11.4 Netherlands Specialty PACS Market By End-User
13.3.3.12 Switzerland
13.3.3.12.1 Switzerland Specialty PACS Market By Component
13.3.3.12.2 Switzerland Specialty PACS Market By Component
13.3.3.12.3 Switzerland Specialty PACS Market By Deployment Model
13.3.3.12.4 Switzerland Specialty PACS Market By End-User
13.3.3.13 Austria
13.3.3.13.1 Austria Specialty PACS Market By Component
13.3.3.13.2 Austria Specialty PACS Market By Component
13.3.3.13.3 Austria Specialty PACS Market By Deployment Model
13.3.3.13.4 Austria Specialty PACS Market By End-User
13.3.3.14 Rest of Western Europe
13.3.3.14.1 Rest of Western Europe Specialty PACS Market By Component
13.3.3.14.2 Rest of Western Europe Specialty PACS Market By Component
13.3.3.14.3 Rest of Western Europe Specialty PACS Market By Deployment Model
13.3.3.14.4 Rest of Western Europe Specialty PACS Market By End-User
13.4 Asia-Pacific
13.4.1 Trend Analysis
13.4.2 Asia-Pacific Specialty PACS Market by Country
13.4.3 Asia-Pacific Specialty PACS Market By Component
13.4.4 Asia-Pacific Specialty PACS Market By Component
13.4.5 Asia-Pacific Specialty PACS Market By Deployment Model
13.4.6 Asia-Pacific Specialty PACS Market By End-User
13.4.7 China
13.4.7.1 China Specialty PACS Market By Component
13.4.7.2 China Specialty PACS Market By Component
13.4.7.3 China Specialty PACS Market By Deployment Model
13.4.7.4 China Specialty PACS Market By End-User
13.4.8 India
13.4.8.1 India Specialty PACS Market By Component
13.4.8.2 India Specialty PACS Market By Component
13.4.8.3 India Specialty PACS Market By Deployment Model
13.4.8.4 India Specialty PACS Market By End-User
13.4.9 Japan
13.4.9.1 Japan Specialty PACS Market By Component
13.4.9.2 Japan Specialty PACS Market By Component
13.4.9.3 Japan Specialty PACS Market By Deployment Model
13.4.9.4 Japan Specialty PACS Market By End-User
13.4.10 South Korea
13.4.10.1 South Korea Specialty PACS Market By Component
13.4.10.2 South Korea Specialty PACS Market By Component
13.4.10.3 South Korea Specialty PACS Market By Deployment Model
13.4.10.4 South Korea Specialty PACS Market By End-User
13.4.11 Vietnam
13.4.11.1 Vietnam Specialty PACS Market By Component
13.4.11.2 Vietnam Specialty PACS Market By Component
13.4.11.3 Vietnam Specialty PACS Market By Deployment Model
13.4.11.4 Vietnam Specialty PACS Market By End-User
13.4.12 Singapore
13.4.12.1 Singapore Specialty PACS Market By Component
13.4.12.2 Singapore Specialty PACS Market By Component
13.4.12.3 Singapore Specialty PACS Market By Deployment Model
13.4.12.4 Singapore Specialty PACS Market By End-User
13.4.13 Australia
13.4.13.1 Australia Specialty PACS Market By Component
13.4.13.2 Australia Specialty PACS Market By Component
13.4.13.3 Australia Specialty PACS Market By Deployment Model
13.4.13.4 Australia Specialty PACS Market By End-User
13.4.14 Rest of Asia-Pacific
13.4.14.1 Rest of Asia-Pacific Specialty PACS Market By Component
13.4.14.2 Rest of Asia-Pacific Specialty PACS Market By Component
13.4.14.3 Rest of Asia-Pacific Specialty PACS Market By Deployment Model
13.4.14.4 Rest of Asia-Pacific Specialty PACS Market By End-User
13.5 Middle East & Africa
13.5.1 Trend Analysis
13.5.2 Middle East
13.5.2.1 Middle East Specialty PACS Market by Country
13.5.2.2 Middle East Specialty PACS Market By Component
13.5.2.3 Middle East Specialty PACS Market By Component
13.5.2.4 Middle East Specialty PACS Market By Deployment Model
13.5.2.5 Middle East Specialty PACS Market By End-User
13.5.2.6 UAE
13.5.2.6.1 UAE Specialty PACS Market By Component
13.5.2.6.2 UAE Specialty PACS Market By Component
13.5.2.6.3 UAE Specialty PACS Market By Deployment Model
13.5.2.6.4 UAE Specialty PACS Market By End-User
13.5.2.7 Egypt
13.5.2.7.1 Egypt Specialty PACS Market By Component
13.5.2.7.2 Egypt Specialty PACS Market By Component
13.5.2.7.3 Egypt Specialty PACS Market By Deployment Model
13.5.2.7.4 Egypt Specialty PACS Market By End-User
13.5.2.8 Saudi Arabia
13.5.2.8.1 Saudi Arabia Specialty PACS Market By Component
13.5.2.8.2 Saudi Arabia Specialty PACS Market By Component
13.5.2.8.3 Saudi Arabia Specialty PACS Market By Deployment Model
13.5.2.8.4 Saudi Arabia Specialty PACS Market By End-User
13.5.2.9 Qatar
13.5.2.9.1 Qatar Specialty PACS Market By Component
13.5.2.9.2 Qatar Specialty PACS Market By Component
13.5.2.9.3 Qatar Specialty PACS Market By Deployment Model
13.5.2.9.4 Qatar Specialty PACS Market By End-User
13.5.2.10 Rest of Middle East
13.5.2.10.1 Rest of Middle East Specialty PACS Market By Component
13.5.2.10.2 Rest of Middle East Specialty PACS Market By Component
13.5.2.10.3 Rest of Middle East Specialty PACS Market By Deployment Model
13.5.2.10.4 Rest of Middle East Specialty PACS Market By End-User
13.5.3 Africa
13.5.3.1 Africa Specialty PACS Market by Country
13.5.3.2 Africa Specialty PACS Market By Component
13.5.3.3 Africa Specialty PACS Market By Component
13.5.3.4 Africa Specialty PACS Market By Deployment Model
13.5.3.5 Africa Specialty PACS Market By End-User
13.5.3.6 Nigeria
13.5.3.6.1 Nigeria Specialty PACS Market By Component
13.5.3.6.2 Nigeria Specialty PACS Market By Component
13.5.3.6.3 Nigeria Specialty PACS Market By Deployment Model
13.5.3.6.4 Nigeria Specialty PACS Market By End-User
13.5.3.7 South Africa
13.5.3.7.1 South Africa Specialty PACS Market By Component
13.5.3.7.2 South Africa Specialty PACS Market By Component
13.5.3.7.3 South Africa Specialty PACS Market By Deployment Model
13.5.3.7.4 South Africa Specialty PACS Market By End-User
13.5.3.8 Rest of Africa
13.5.3.8.1 Rest of Africa Specialty PACS Market By Component
13.5.3.8.2 Rest of Africa Specialty PACS Market By Component
13.5.3.8.3 Rest of Africa Specialty PACS Market By Deployment Model
13.5.3.8.4 Rest of Africa Specialty PACS Market By End-User
13.6 Latin America
13.6.1 Trend Analysis
13.6.2 Latin America Specialty PACS Market by country
13.6.3 Latin America Specialty PACS Market By Component
13.6.4 Latin America Specialty PACS Market By Component
13.6.5 Latin America Specialty PACS Market By Deployment Model
13.6.6 Latin America Specialty PACS Market By End-User
13.6.7 Brazil
13.6.7.1 Brazil Specialty PACS Market By Component
13.6.7.2 Brazil Specialty PACS Market By Component
13.6.7.3 Brazil Specialty PACS Market By Deployment Model
13.6.7.4 Brazil Specialty PACS Market By End-User
13.6.8 Argentina
13.6.8.1 Argentina Specialty PACS Market By Component
13.6.8.2 Argentina Specialty PACS Market By Component
13.6.8.3 Argentina Specialty PACS Market By Deployment Model
13.6.8.4 Argentina Specialty PACS Market By End-User
13.6.9 Colombia
13.6.9.1 Colombia Specialty PACS Market By Component
13.6.9.2 Colombia Specialty PACS Market By Component
13.6.9.3 Colombia Specialty PACS Market By Deployment Model
13.6.9.4 Colombia Specialty PACS Market By End-User
13.6.10 Rest of Latin America
13.6.10.1 Rest of Latin America Specialty PACS Market By Component
13.6.10.2 Rest of Latin America Specialty PACS Market By Component
13.6.10.3 Rest of Latin America Specialty PACS Market By Deployment Model
13.6.10.4 Rest of Latin America Specialty PACS Market By End-User
14. Company Profiles
14.1 Canon Inc.
14.1.1 Company Overview
14.1.2 Financial
14.1.3 Products/ Services Offered
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Siemens Healthineers
14.2.1 Company Overview
14.2.2 Financial
14.2.3 Products/ Services Offered
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 McKesson Corporation INC
14.3.1 Company Overview
14.3.2 Financial
14.3.3 Products/ Services Offered
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 Escalon Medical Corp.
14.4.1 Company Overview
14.4.2 Financial
14.4.3 Products/ Services Offered
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 Intelerad Medical Systems
14.5.1 Company Overview
14.5.2 Financial
14.5.3 Products/ Services Offered
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 Eye PACS, LLC
14.6.1 Company Overview
14.6.2 Financial
14.6.3 Products/ Services Offered
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 IBM Corporation
14.7.1 Company Overview
14.7.2 Financial
14.7.3 Products/ Services Offered
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 Sectra AB
14.8.1 Company Overview
14.8.2 Financial
14.8.3 Products/ Services Offered
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 INFINITT Healthcare Co. Ltd.
14.9.1 Company Overview
14.9.2 Financial
14.9.3 Products/ Services Offered
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Topcon Corporation
14.10.1 Company Overview
14.10.2 Financial
14.10.3 Products/ Services Offered
14.10.4 SWOT Analysis
14.10.5 The SNS View
14.11 Novarad
14.11.1 Company Overview
14.11.2 Financial
14.11.3 Products/ Services Offered
14.11.4 SWOT Analysis
14.11.5 The SNS View
14.12 Onex Corporation (Carestream Health)
14.12.1 Company Overview
14.12.2 Financial
14.12.3 Products/ Services Offered
14.12.4 SWOT Analysis
14.12.5 The SNS View
14.13 Philips Healthcare
14.13.1 Company Overview
14.13.2 Financial
14.13.3 Products/ Services Offered
14.13.4 SWOT Analysis
14.13.5 The SNS View
14.14 Agfa Healthcare
14.14.1 Company Overview
14.14.2 Financial
14.14.3 Products/ Services Offered
14.14.4 SWOT Analysis
14.14.5 The SNS View
14.15 Visbion
14.15.1 Company Overview
14.15.2 Financial
14.15.3 Products/ Services Offered
14.15.4 SWOT Analysis
14.15.5 The SNS View
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions
16. Use Case and Best Practices
17. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Platelet Rich Plasma Market was valued at USD 0.75 billion in 2023 & is expected to reach USD 2.62 billion by 2032, growing at a CAGR of 14.98% from 2024-2032.
The Pulsed Field Ablation Market Size, valued at USD 110.8 million in 2023 and projected to reach USD 2127.9 million by 2032, With a CAGR of 38.9%
The Antimicrobial Susceptibility Testing Market Size was valued at USD 3.57 billion in 2023 and is expected to reach USD 5.35 billion by 2031 and grow at a CAGR of 5.2% over the forecast period 2024-2031.
The Spinal Muscular Atrophy Treatment Market size was estimated at USD 4.48 billion in 2023 and is expected to reach USD 8.16 billion by 2032 at a CAGR of 6.9% during the forecast period of 2024-2032.
The Bioremediation Market size was estimated at USD 14.95 billion in 2023 and is expected to reach USD 34.27 billion by 2032 with a growing CAGR of 9.69% during the forecast period of 2024-2032.
The Medical Swabs Market was valued at USD 3.15 billion in 2023 and is expected to reach USD 5.69 billion by 2032, growing at a CAGR of 6.8% by 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
